Category Archives: Stem Cell Research

Harvesting human stem cells for scientific advancements continues to provoke ethical questions and controversies. However, scientists continue to find new ways to use stem cells derived from fruit and plants in formulating thier skin care products such as found in the Vargas Cosmetics' Tilth Beauty brand. Monroe, CT (PRWEB) February 15, 2013 This plant contains adaptogens which has shown to protect, nurture and heal damaged cells. The Edelweiss plant (Liontopodium alpinum) is a scarce short-lived mountain flower found sporadically around rocky limestone areas at about 1800-3000 meters in altitude and is frequently associated with the Swiss Alps. This flowers protective characteristics contribute to its organic anti-aging properties. Edelweiss stem cells are shown to visible reduce signs of aging, provide significant antioxidant benefits, and limit degradation of skin collagen and firmness. Skin care scientist and founder of Vargas Cosmetics, Anthony Vargas, uses Edelweiss Stem Cells for Eye Wondrous Serum, which is part of his Tilth Beauty premium anti-aging skin care line. This advanced eye serum formulation also includes potent peptides, encapsulated retinol, along with a plethora of other proven botanical and scientific ingredients. The serums synergy of anti-aging ingredients visibly reduces the appearance of wrinkles, while improving hydration, elasticity and firmness … Continue reading →

CARLSBAD, CA--(Marketwire - Feb 15, 2013) - International Stem Cell Corporation ( OTCQB : ISCO ) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company, today announced amendments to the license agreements with Advanced Cell Technology, Inc. The license agreements, first entered into in 2004 and amended in 2005, granted ISCO access to a range of ACT's patents and patent applications for the use of various technologies in a limited set of human tissues. The amendments extend ISCO's existing rights in the area of parthenogenesis, and the therapeutic use of parthenogenetically derived stem cells for treating any human diseases. Pursuant to the amended agreements ISCO now has an exclusive world-wide license to ACT's patents and applications covering the uses of parthenogenetically derived stem cells in generating human tissue. "We're excited to have extended our portfolio of intellectual property which not only allows us to develop new therapeutic and business opportunities, but also makes the possibility of partnering with big pharma practical," commented Dr. Andrey Semechkin, CEO and Co-Chairman of ISCO. About International Stem Cell CorporationInternational Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic … Continue reading →

GENETIC FEAR OF A BLACK PLANET WORLD TOUR INTRO This Video Details the World Tour of the Genetic Fear of a Black Planet. We are Challenging all European Biologists Geneticists Medical Doctors Astro Physicists Cosmologists from our stance in The Aboriginal Moorish and African Paradigm of Science versus the European Models On Every aspect of Science specifically the differences between the anatomy Physiology of the races and the miseducation about the true power of the Black Body. We are here To Educate Black People About the Bio-Genetic Suppression of Information concerning their genetics and its importance to world economic systems world medical systems Stem Cell Research Organ Regeneration Artificial Intelligence and a Eugenics Program made to keep them permanent slaves and or face GENE-OCIDE By: aboriginalglobamedia … Continue reading →

Dear Religion (an open letter) or Why Adam and Eve it- Cockneycpl's Channel: http://www.youtube.com Original Video: http://www.youtube.com Original Description: "Dear religion, Kindly stop deceiving yourself and others, grow up and take responsibility for your actions, and the actions of what others do in your name. If you want to be taken seriously you would not contradict yourself, and If you want to be believed, you would and should be able to back up your claims with reliable and certifiable evidence. If you want to be thought off as benevolent, why hinder the advancement of treatments that work to cure people? (Like stem cell research). If you want us to be good to everyone why do you have such hate and intolerance to others in your writings. All of you can't all be right as you all claim to be, that leads me to the conclusion that none of you are right. As you built and expanded on from each other's ideas. (If even one thing is in error then your whole premise fails) and I'm looking at you Adam Eve. If you can prove that none of your authors were delusional, and that anything you say … Continue reading →

The Parkinson's Insitute Stem Cell Passaging Video Video tutorial demonstrating two methods of passaging stem cell cultures. By: ParkinsonInstitute … Continue reading →

Pope Resigns 2013 - Pope Benedict XVI Resigns 2013 - Resignation of Pope Benedict XVI - 2/11/13 Pope Resigns 2013 - Pope Benedict XVI Resigns 2013 - Resignation of Pope Benedict XVI Vatican - 2/11/13 Resignation ROME mdash; Citing advanced years and infirmity, Pope Benedict XVI, the former Cardinal Joseph Ratzinger, stunned the Roman Catholic world on Monday by saying that he would resign on Feb. 28, less than eight years after he took office, the first pope to do so in six centuries. A profoundly conservative figure whose papacy was overshadowed by clerical abuse scandals, the pope, 85, was elected by fellow cardinals in 2005 after the death of his predecessor, John Paul II. After examining his conscience "before God," he said on Monday, "I have come to the certainty that my strengths, due to an advanced age, are no longer suited to an adequate exercise" of his position as head of the world's Roman Catholics. Federico Lombardi, the Vatican spokesman, said Benedict would continue to carry out his papal duties until Feb. 28 and that a successor could probably be elected by Easter which falls this year on March 31. But, he added, that date was "not … Continue reading →

Oratory Contest Grand Rapids Right to Life will sponsor the 24th Annual Prolife Oratory Contest. This is a great way for high school students to practice their research and public speaking skills. Each student who enters the contest will prepare a 5-7 minute speech on one of these prolife issues: Abortion, Infanticide, Euthanasia, Human Cloning, or Embryonic Stem Cell Research. The top three finalists will earn cash prizes! Details at: grrtl.org By: GRRTL … Continue reading →

Regenerative medicine and Stem cells Partnering Terms and Agreements is the new market research report added to ReportsnReports.com store. Dallas, TX (PRWEB) February 12, 2013 The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine and stem cells partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors regenerative medicine and stem cells technology. These deals tend to be multi component, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest regenerative medicine and stem cells agreements including cell therapy agreements announced in the healthcare sector. Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases and databases do not. This report contains a comprehensive listing of all regenerative medicine and stem cells partnering deals announced since 2008 including financial terms were … Continue reading →

Stem cells of the aging bone marrow recycle their own molecules to survive and keep replenishing the blood and immune systems as the body ages, researchers at UC San Francisco (UCSF) have discovered. The recycling process, known as autophagy, or self-eating, involves reusing molecules and the chemical energy obtained from these molecules to withstand the killing effect of metabolic stress that intensifies as the body ages. Emmanuelle Passegu, PhD The discovery, reported online Feb. 6 in the journal Nature, showed that autophagy allows stem cells to avoid the alternative response to stress, which is programmed cellular suicide, in which cells that arent up to snuff kill themselves for the greater good. While this trick of autophagy may help delay the onset of anemia, immune-system failure and other maladies that occur with age, as a survival strategy it is a bit of a compromise, said the senior author of the study, Emmanuelle Passegu, PhD, of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF. Autophagy might increase cancer risk, she said, by allowing old stem cells to survive despite having accumulated risky mutations over a lifetime. Almost all blood malignancies start in the stem cell … Continue reading →

BEVERLY, MA and TORONTO--(Marketwire - Feb 11, 2013) - Hamilton Thorne Ltd. ( TSX VENTURE : HTL ), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year-ended December 31, 2012. "Our preliminary unaudited results show that Hamilton Thorne's fourth quarter sales increased to approximately $2.05 million, up 41% versus the third quarter of 2012 and up 2% versus the same quarter last year," said David Wolf, President and Chief Executive Officer of Hamilton Thorne Ltd."More importantly, we generated approximately $150,000 of positive cash flow for the quarter due to the combination of strong sales and the full impact of the strategic cost cutting that we executed in the third quarter." Sales growth was driven by increased demand for the Hamilton Thorne's best-of-class CASA II image analysis systems which were introduced at the end of the third quarter and shipped in quantity in Q4.Total preliminary sales for the year were approximately $6.3 million. Mr. Wolf continued, "In 2013, we expect to continue to invest in product enhancements and sales and marketing activities, in order to … Continue reading →